3DNA structures are three dimensional nanoscaffolds made entirely from DNA, engineered for stability and multivalency. 3DNA nanocarriers have been fine-tuned for unique applications in targeted therapeutics, clinical diagnostics, and life science research.
The 3DNA platform offers unique adaptations in immuno-oncology and gene editing, as well as delivery to the eye and brain. Genisphere seeks additional collaborations to improve efficacy and reduce toxicity of clinically relevant small drugs, biologics, and nucleic acids.
Genisphere is pursuing its own pipeline of lead drug candidates based on the 3DNA platform. Pre-clinical advances have supported Genisphere's lead development programs and have resulted in a rich pipeline for a variety of indications.